NEWSROOM

NASDAQ

Former Merck USA President Joins Klotho Neurosciences’ Board of Directors

Former Merck USA President Joins Klotho Neurosciences’ Board of Directors

Highly Accomplished Pharmaceutical Leader, Riad El-Dada, Further Enhances Board Expertise NEW YORK, Dec. 03, 2024 - PRISM MediaWire - Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biotechnology company pioneering cell and gene therapies for neurodegenerative and age-related disorders, including ALS, Alzheimer’s, and Parkinson’s, today announced the appointment of Riad El-Dada, former US President of Merck, to its Board of Directors. With decades of leadership in the pharmaceutical...

read more
Lipella Pharmaceuticals Announces Publication in CUREUS on Non-Steroid Treatment of Oral Lichen Planus

Lipella Pharmaceuticals Announces Publication in CUREUS on Non-Steroid Treatment of Oral Lichen Planus

Peer-reviewed article highlights potential treatment for OLP with focus on localized drug delivery PITTSBURGH, Dec. 03, 2024 - PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotechnology company dedicated to addressing serious diseases with significant unmet needs, today announced the publication of a peer-reviewed paper in CUREUS. Titled “Rationale for the Use of Topical Calcineurin Inhibitors in the Management of Oral Lichen Planus and Mucosal...

read more
Oncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms 

Oncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms 

Oncocyte first to published randomized interventional data to rule-in for biopsy in high-risk patient population  Study shows that monitoring with Oncocyte’s assay significantly reduces time to rejection diagnosis in patients with newly developed donor-specific antibodies  Early detection of transplant rejection is growing in significance as novel therapeutic treatments show promising early results in antibody mediated rejection.  Study published in Nephrology Dialysis...

read more
SKYX to Present at Noble Capital Markets’ NobleCon20 on December 3, 2024

SKYX to Present at Noble Capital Markets’ NobleCon20 on December 3, 2024

Rani Kohen, Founder, and Steve Schmidt, President of SKYX, to Present at 1:30 PM ET on December 3, 2024, and Engage in Investor Meetings Throughout the Conference MIAMI, Nov. 27, 2024 - PRISM MediaWire - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 97 issued and pending patents in the U.S. and globally, and over 60 lighting and home décor websites with a mission to make homes and buildings become smart, safe,...

read more
AmpliTech Group Announces Closing of $1.4 Million Registered Direct Offering

AmpliTech Group Announces Closing of $1.4 Million Registered Direct Offering

HAUPPAUGE, N.Y., Nov. 26, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW) (the “Company”), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced it has closed on its previously announced registered direct offering for the sale...

read more
EzFill Signs Definitive Agreement for the Purchase of Yoshi Mobility’s Fuel Division

EzFill Signs Definitive Agreement for the Purchase of Yoshi Mobility’s Fuel Division

Agreement Expands EzFill’s Operations to Four New States Deal Expected to Close December 2 Miami, FL, November 25, 2024 - PRISM MediaWire - EzFill Holdings Inc. (NASDAQ: EZFL), a leading mobile fueling company, has signed a definitive agreement to acquire the fueling division of Yoshi, Inc.  with the aim of expanding its U.S operations and presence. Under the terms of the agreement, EzFill will acquire Yoshi Mobility’s existing mobile fuel service assets and allows EzFill to begin operations...

read more
AmpliTech Group Announces Closing of $1.4 Million Registered Direct Offering

AmpliTech Group Announces Pricing of $1.4 Million Registered Direct Offering, Priced At-The-Market

HAUPPAUGE, N.Y., Nov. 25, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW) (the “Company”), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced that it has entered into one or more securities purchase agreements with certain...

read more
Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of LP-310 for Oral Lichen Planus, Advancing to Next Dose Group

Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of LP-310 for Oral Lichen Planus, Advancing to Next Dose Group

PITTSBURGH, November 21, 2024 - PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on innovative therapies for serious diseases with significant unmet needs, today announced the completion of dosing for the first cohort in its multi-center Phase 2a clinical trial of LP-310, a liposomal-tacrolimus oral rinse being developed for the treatment of Oral Lichen Planus (OLP). In this first cohort, eight...

read more
LuxUrban Hotels Inc. Signs A Non-Binding Letter of Intent for Proposed Joint Venture with Lockwood Development Partners LLC and The Bright Hospitality Management to Elevate Hotel Operations and Guest Experience

LuxUrban Hotels Inc. Signs A Non-Binding Letter of Intent for Proposed Joint Venture with Lockwood Development Partners LLC and The Bright Hospitality Management to Elevate Hotel Operations and Guest Experience

Strategic initiative would provide LuxUrban with a $7 million initial capital infusion, offering the opportunity to broaden its market impact representing a key milestone in building Lux 2.0 Joint venture would leverage advanced technology integration to streamline operations, elevate service offerings, and deliver an enhanced guest experience MIAMI, November 20, 2024 - PRISM MediaWire - LuxUrban Hotels Inc. (Nasdaq: LUXH), a hospitality company that leases entire hotels on a long-term basis,...

read more
LuxUrban Hotels Inc. Signs A Non-Binding Letter of Intent for Proposed Joint Venture with Lockwood Development Partners LLC and The Bright Hospitality Management to Elevate Hotel Operations and Guest Experience

LuxUrban Hotels Inc. Reports Third Quarter 2024 Financial Results

MIAMI, November 20, 2024 - PRISM MediaWire - LuxUrban Hotels Inc. (Nasdaq: LUXH), a hospitality company that leases entire hotels on a long-term basis, manages these hotels, and rents out rooms to guests in the properties it leases, today announced its financial results for the third quarter ended September 30, 2024 (“Q3 2024”). The Company filed its quarterly report on Form 10-Q for Q3 2024 with the U.S. Securities and Exchange Commission on November 19, 2024 Q3 2024 Financial Overview: Net...

read more
SKYX to Present at Noble Capital Markets’ NobleCon20 on December 3, 2024

SKYX to Participate in the 13th Annual ROTH Technology Conference in New York City November 19-20, 2024

MIAMI, Nov. 18, 2024 - PRISM MediaWire - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), a highly disruptive platform technology company with over 97 pending and issued patents globally and over 60 lighting and home décor websites, with a mission to make homes and buildings become safe and smart as the new standard, today announced participation in the upcoming 13th Annual Roth Technology Conference to be held on November 19 - 20, 2024 at the Hard Rock...

read more
AmpliTech Group Announces Closing of $1.4 Million Registered Direct Offering

AmpliTech Group’s AmpliTech Inc. Division Secures Initial Purchase Order Under 5-Year Basic Order Agreement With Fortune 1000 U.S. Company

PO Valued At Close To US$1 Million for LNB Products And Engineering Services Hauppauge, NY, November 18, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced receiving an...

read more
LuxUrban Hotels Inc. Signs A Non-Binding Letter of Intent for Proposed Joint Venture with Lockwood Development Partners LLC and The Bright Hospitality Management to Elevate Hotel Operations and Guest Experience

LuxUrban Hotels Inc. Announces Reverse Stock Split and Nasdaq Compliance Approval

Miami, Florida, November 15, 2024 - PRISM MediaWire - LuxUrban Hotels Inc. (Nasdaq: LUXH), a hospitality company that leases entire hotels on a long-term basis, manages these hotels, and rents out rooms to guests in the properties it leases, today announced that it will effectuate a one-for-seventy (1:70) reverse stock split of its common stock. This reverse stock split was approved by stockholders at the special meeting held on November 12, 2024, and will be effective at the opening of...

read more
AmpliTech Group Announces Closing of $1.4 Million Registered Direct Offering

AmpliTech Group Reports 2.8M revenue, 1.3M Gross profits, 47% Gross Margins

Hauppauge, NY, November 15, 2024 – PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced its financial results for the third quarter ended September 30, 2024. Q3 2024 Highlights...

read more
AmpliTech Group Announces Closing of $1.4 Million Registered Direct Offering

AmpliTech Group’s AmpliTech Inc Division Signs 5 Year BOA (Basic Order Agreement) With Fortune 1000 US Company For LNB Products

Hauppauge, NY, November 14, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced the signing of a 5-Year Basic Order Agreement (BOA), to provide a US-based Fortune 1000 Company...

read more
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index

Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index

Company advancing late-stage clinical programs with novel therapies that target underserved heart diseases NEW YORK, November 13, 2024 - PRISM MediaWire - PRISM MarketView, a leading provider of market insights and company news, proudly announces that Cardiol Therapeutics Inc. (NASDAQ: CRDL, TSX: CRDL) has been added to the PRISM Emerging Biotech Index, which spotlights companies leading innovation and creating market impact within the biotech sector. Cardiol’s focus on anti-inflammatory and...

read more
SKYX to Present at Noble Capital Markets’ NobleCon20 on December 3, 2024

SKYX Reports Record Sales of $22.2 Million for Third Quarter Compared to $21.6 Million for Third Quarter 2023 as it Continues to Grow its Market Penetration of its Advanced and Smart Platform Products in the U.S and Canadian Markets

MIAMI, FL, November 12, 2024 – PRISM MediaWire - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), a highly disruptive platform technology company with over 97 pending and issued patents globally and over 60 lighting and home décor websites, with a mission to make homes and buildings become safe and smart as the new standard, today reported its financial and operational results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights...

read more
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025

Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025

Transplant centers representing about 9% of German transplant volumes and about 2% of U.S. transplant volumes have signed on to use GraftAssure kitted research test in early launch phase FDA pre-submission process for approval of kitted clinical test is underway IRVINE, Calif., Nov. 12, 2024 - PRISM MediaWire - Oncocyte Corporation (Nasdaq: OCX) (“Oncocyte” or the “Company”), a diagnostics technology company, today published the following letter to shareholders in conjunction with its third...

read more
ClearTrust Announces Integration with VOTR to Transform Shareholder Communications

ClearTrust Announces Integration with VOTR to Transform Shareholder Communications

Creates New Standard for Shareholder Management Capabilities Enables Unprecedented Data-Driven Insights for Issuers TAMPA, Fla., Nov. 12, 2024 - PRISM MediaWire - Setting a new standard in transfer agent services, ClearTrust, LLC ("ClearTrust") today announced its integration with VOTR's technology-enabled proxy and shareholder communications platform. This strategic integration marks an industry first and represents a significant advancement in how public companies manage and track their...

read more
Lipella Pharmaceuticals Secures Extended Market Exclusivity with Issuance of U.S. Patent for Liposomal Delivery Platform

Lipella Pharmaceuticals Secures Extended Market Exclusivity with Issuance of U.S. Patent for Liposomal Delivery Platform

PITTSBURGH, November 12, 2024 - PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotechnology company focused on developing innovative therapies for serious diseases with unmet medical needs, today announced that U.S. Patent No. 12,138,345 for its proprietary liposomal drug delivery platform will be officially issued by the U.S. Patent and Trademark Office (USPTO) on November 12, 2024. This patent, titled "Delivery of Agents Using Metastable Liposomes," covers...

read more
SKYX to Present at Noble Capital Markets’ NobleCon20 on December 3, 2024

SKYX Announces Corporate Update Call

Company to Provide Corporate Updates Including New Developments and Third Quarter 2024 Financial Results; Conference Call to be Held on Tuesday, November 12, 2024, at 4:30 PM Eastern Time Miami, November 8, 2024 - PRISM MediaWire - SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 97 issued and pending patents in the U.S. and globally, and which owns over 60 lighting and home décor websites with a mission to make homes and...

read more
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025

Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12

Conference Call and Webcast on Tuesday, November 12, 2024, at 2:00 p.m. PT / 5:00 p.m. ET IRVINE, Calif., Nov. 6, 2024 - PRISM MediaWire -  Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, announced today that the company will release its third quarter 2024 financial results on Tuesday, November 12, 2024, after U.S. market closes. The company will also host a conference call and webcast on Tuesday, November 12, 2024, at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss...

read more
SKYX to Present at Noble Capital Markets’ NobleCon20 on December 3, 2024

SKYX to be a Main Event at TheRealDeal Miami Real-Estate Forum & Developer Showcase Tomorrow November 6

As SKYX Continues to Enhance its Market Penetration in the US and Canada it Will Showcase its Patented Game-Changing Smart Home Platform Technologies with High-End Real-Estate Developers and Industry Professionals Miami, FL, November 5, 2024 - PRISM MediaWire - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 97 issued and pending patents in the U.S. and globally, and over 60 lighting and home décor websites with a...

read more
Sono-Tek Announces Share Buyback

Sono-Tek Announces Share Buyback

MILTON, N.Y., November 4, 2024 - PRISM MediaWire - Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that its Board of Directors has authorized the repurchase of up to $2.0 million of Sono-Tek’s outstanding common stock (the “Repurchase Program”). “We are pleased to announce the Repurchase Program and believe that it demonstrates our financial strength and confidence in our long-term growth strategy. With our solid...

read more
Lipella Pharmaceuticals Secures Extended Market Exclusivity with Issuance of U.S. Patent for Liposomal Delivery Platform

Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split

PITTSBURGH, PA, November 1, 2024 - PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (the “Company,” “our” or “us”), a clinical-stage biotechnology company focused on developing innovative therapies for serious diseases with unmet medical needs, today announced that it intends to effect a 1-for-8 reverse stock split of its common stock effective as of 5:00 p.m. Eastern Time on November 7, 2024 upon the filing of a certificate of amendment to the Company’s certificate of...

read more
HUB Security to Present at the 2024 ThinkEquity Conference

HUB Security to Present at the 2024 ThinkEquity Conference

Tel Aviv, Israel, October 30, 2024 - PRISM MediaWire - HUB Cyber Security Ltd. (NASDAQ: HUBC) ("HUB Security" or the "Company"), a leading provider of cybersecurity solutions and advanced data fabric, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking innovations and...

read more
Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of LP-310 for Oral Lichen Planus, Advancing to Next Dose Group

Lipella Pharmaceuticals to Present at 2024 Spartan Capital Investor Conference

PITTSBURGH, Pa., Oct. 29, 2024 – PRISM MediaWire - Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious diseases with significant unmet needs, today announced that CEO Jonathan Kaufman, PhD will be presenting at the 2024 Spartan Capital Investor Conference that is being held on November 4, 2024, at the Pierre Hotel in New York. Event: Lipella Presentation - 2024 Spartan Capital Investor Conference Date:...

read more
AmpliTech Group’s AGTGSS Division Releases New Portable 5G Networks In A Box (NIB) For Military, First Responders, And On-Demand Commercial Events

AmpliTech Group’s AGTGSS Division Releases New Portable 5G Networks In A Box (NIB) For Military, First Responders, And On-Demand Commercial Events

New Products Include Backpack, Rolling Suitcase and Vehicle Mounted NIB’s Hauppauge, NY, October 29, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced the release of its...

read more
Sono-Tek Announces Participation at The Spartan Capital Investor Conference

Sono-Tek Announces Participation at The Spartan Capital Investor Conference

Premier Event to Showcase Growth Companies and Foster High-Level Investor Engagement MILTON, N.Y., October 29, 2024 - PRISM MediaWire - Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced its participation in Spartan Capital Securities, LLC's inaugural investor conference on November 4th at the Pierre Hotel in New York. Steve Harshbarger, CEO & President of Sono-Tek will provide a formal presentation to investor...

read more
IBC Advanced Alloys to Present on October 30 at the 2024 ThinkEquity Conference

IBC Advanced Alloys to Present on October 30 at the 2024 ThinkEquity Conference

Presentation to be Webcast Live at 11:30 a.m. Eastern New York, New York, October 28, 2024 - PRISM MediaWire - IBC Advanced Alloys (“IBC” or the “Company”) (TSX-V: IB; OTCQB: IAALF), a leading U.S. producer of copper alloy products to defense and commercial markets, announces that it will be participating in the ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other...

read more

Contact Us

PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850